Key facts
- This page summarizes Eric Francis Yves Thepaut's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 May 2024, 16:41.
Eric Francis Yves Thepaut - 10 May 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)
- Reporting relationship
- EVP & Pres, Eur, Mid-East, Afr
- Issuer ticker
- BSX
- Reported as of
- 10 May 2024
- Net transaction value
- -$747,813
- SEC form
- 4
- Accepted by SEC
- 13 May 2024, 16:41:24 UTC
- Prior SEC filing
- 20 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Thompson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Francis Yves Thepaut filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 13 May 2024.
Change
- Previous filing in this sequence was filed on 20 Feb 2024.
- Current net transaction value: -$747,813.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $210,905
- Shares
- +12,931
- Change %
- +41%
- Price
- $16.31
- Shares after
- 44,353
- Date
- 10 May 2024
- Ownership
- Direct
BSX
transaction
Common Stock
Sale
- Transaction value
- $958,717
- Shares
- -12,931
- Change %
- -29%
- Price
- $74.14
- Shares after
- 31,422
- Date
- 10 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -12,931
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,931
- Exercise price
- $16.31
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.165, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.